The reduction in price target by Oppenheimer, despite maintaining an Outperform rating, could lead to short-term negative sentiment among investors. This significant adjustment in the price target might be interpreted as a recalibration of expectations towards the company's future performance, potentially impacting investor confidence and the stock's price in the short term.